Amy Hartl, PhD SHL Medical

Dr. Amy Hartl has been working at SHL since 2016. As Director of Process Development, Dr. Hartl oversees the operations, testing, and statistical analyses that are crucial for the successful design transfer of autoinjector devices from development to commercialization. The process development team develops, validates, and transfers device testing, final assembly, device labeling, final packaging, and serialization processes. In parallel, her team also develops strategies for increasing and optimizing the site’s capacity by implementing high-speed equipment, expanding technological capabilities, and leaning out existing processes.

Prior to joining the medical device industry, Dr. Hartl taught Statistics and Experimental Design courses at Florida Atlantic University where she also obtained her Ph.D. in Experimental Psychology.